Vexev raises $8.6M for medical imaging platform

• Medical technology startup Vexev has secured $8.6 million in new capital to accelerate commercial development.
• The funding round brings the private company's total capital raised to $27 million.
• The proceeds will support regulatory clearance and clinical application of its automated ultrasound platform.

Medical technology startup Vexev has raised $8.6 million to fund regulatory clearance for its automated imaging platform.

The new investment capital increases the Sydney-based company's total funding to $27 million.

"We believe high-quality vascular imaging should be available wherever patients receive care," said Vexev CEO John Carroll.

The company stated that the platform is initially being developed for upper-limb vascular imaging in dialysis patients.

The technology combines robotics, artificial intelligence, and ultrasound to automate non-invasive medical imaging processes.

New investors TreeArc Investment Group, TEN13, Bioshore Ventures, and Alumni Ventures backed the funding round.